Evaluating the Efficacy of Subcutaneous C1-Esterase Inhibitor Administration for Use in Rat Models of Inflammatory Diseases

Drug Delivery - United Kingdom
doi 10.3109/10717544.2013.853211
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Safety, Efficacy, and Pharmacokinetics of Intravenous C1 Esterase Inhibitor (Human) Prophylaxis in Children With Hereditary Angioedema (HAE)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

C1-Esterase Inhibitor (C1INH) Implication in Systemic Inflammation in Sepsis

Critical Care
Critical CareIntensive Care Medicine
2010English

Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema Due to C1-Esterase Inhibitor Deficiency

Journal of Emergency Medicine
Emergency Medicine
2016English

Falsely Normal C4 in a Case of Acquired C1 Esterase Inhibitor Deficiency

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Pasteurized and Nanofiltered, Plasma-Derived C1 Esterase Inhibitor Concentrate for the Treatment of Hereditary Angioedema

Immunotherapy
OncologyAllergyImmunology
2014English

Long-Term Safety of Subcutaneous C1-Inhibitor in the Prophylactic Treatment of Hereditary Angioedema

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Bench-To-Bedside Review: The Role of C1-Esterase Inhibitor in Sepsis and Other Critical Illnesses

Critical Care
Critical CareIntensive Care Medicine
2010English

Administration of C1 Inhibitor Reduces Neutrophil Activation in Patients With Sepsis

Clinical Diagnostic Laboratory Immunology
2003English

Co-Occurrence of C1 Esterase Inhibitor Deficiency and Autoimmune Disease: A Systematic Literature Review

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy